A phase I/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumours

被引：4
|
作者：
Luke, J. J. [1 ]
Janku, F. [2 ]
Strauss, J. [3 ]
Olszanski, A. J. [4 ]
Leach, K. [5 ]
Radhakrishnan, I. [5 ]
Abbas, A. [5 ]
机构：
[1] UPMC Hillman Canc Ctr, Med, Pittsburgh, PA USA
[2] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
[3] Mary Crowley Med Res Ctr, Oncol, Dallas, TX USA
[4] Fox Chase Canc Ctr, Med Oncol, Main Campus, Philadelphia, PA 19111 USA
[5] Spring Bank Pharmaceut, Oncol Dept, Hopkinton, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
598TiP
引用
收藏
页码：S500 / S500
页数：1
相关论文
共 50 条
  • [41] Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies
    Salgia, Ravi
    Patel, Premal
    Bothos, John
    Yu, Wei
    Eppler, Steve
    Hegde, Priti
    Bai, Shuang
    Kaur, Surinder
    Nijem, Ihsan
    Catenacci, Daniel V. T.
    Peterson, Amy
    Ratain, Mark J.
    Polite, Blase
    Mehnert, Janice M.
    Moss, Rebecca A.
    CLINICAL CANCER RESEARCH, 2014, 20 (06) : 1666 - 1675
  • [42] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [43] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Capecitabine (Xeloda®) in combination with oxaliplatin:: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors
    Díaz-Rubio, E
    Evans, TRJ
    Tabernero, J
    Cassidy, J
    Sastre, J
    Eatock, M
    Bisset, D
    Regueiro, P
    Baselga, J
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 558 - 565
  • [45] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Véronique Diéras
    Thomas Bachelot
    Mario Campone
    Nicolas Isambert
    Florence Joly
    Christophe Le Tourneau
    Philippe Cassier
    Emmanuelle Bompas
    Pierre Fumoleau
    Sabine Noal
    Christine Orsini
    Marta Jimenez
    Diane Charlotte Imbs
    Etienne Chatelut
    Oncology and Therapy, 2016, 4 (2) : 211 - 223
  • [46] A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours
    Li, Xiaoyu
    Qiu, Meng
    Wang, ShengJun
    Zhu, Hong
    Feng, Bi
    Zheng, Li
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 593 - 604
  • [47] Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors
    Bendell, JC
    Eder, JP
    Clark, JW
    Fidias, P
    Lynch, TJ
    Seiden, MV
    Ryan, DP
    CANCER, 2005, 103 (09) : 1925 - 1931
  • [48] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Dieras, Veronique
    Bachelot, Thomas
    Campone, Mario
    Isambert, Nicolas
    Joly, Florence
    Le Tourneau, Christophe
    Cassier, Philippe
    Bompas, Emmanuelle
    Fumoleau, Pierre
    Noal, Sabine
    Orsini, Christine
    Jimenez, Marta
    Imbs, Diane Charlotte
    Chatelut, Etienne
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223
  • [49] A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
    Mettu, Niharika B.
    Ulahannan, Susanna, V
    Bendell, Johanna C.
    Garrido-Laguna, Ignacio
    Strickler, John H.
    Moore, Kathleen N.
    Stagg, Robert
    Kapoun, Ann M.
    Faoro, Leonardo
    Sharma, Sunil
    CLINICAL CANCER RESEARCH, 2022, 28 (05) : 882 - 892
  • [50] A phase I dose-escalation study of RAD001 administered daily to Japanese patients with advanced solid tumors
    Doi, T.
    Ohtsu, A.
    Nakagawa, K.
    Okamoto, I.
    Kurei, K.
    Kobayashi, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 114 - 114
12345